chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Colonoscopy, Computerised tomogram abdomen normal, Condition aggravated, Cough, Diarrhoea
Clinical narrative: Patient is a 63 y.o. female with a history of IDDM2 on U-500, Afib on Eliquis, chronic systolic CHF, ESRD on HD, and multiple recent hospital admists 8/11-8/21/23 for acute CHF and started on HD, 8/23-9/2/23 for R ankle fracture s/p ORIF and 9/15-9/20/23 for hypoglycemia and discharged home with HHC. She presented to hospital 9/23/2023 with 1 day history of fever, dyspnea and cough and was found to have COVID 19. Course complicated by Bifidobacterium bacteremia.    1. COVID 19: 1 day history of fever, productive cough and shortness of breath.  COVID-19 positive on admit.  Chest x-ray on admit nonacute.  Patient on baseline oxygen requirement.  ID followed, remdesivir thru 9/29/23.  2. Bifidobacterium bacteremia: 1/2 bottle from 9/23/23. Started on unasyn 9/25/23. Repeat blood cx 9/25/23, negative so far. ID followed, recommended CT Ab/pelvis which was non acute, and Unasyn continued thru 9/29/23. 3. Nausea, diarrhea, Bloody stools: C diff neg. Eliquis held, restarted 9/29/23. Zofran, PPI ordered. GI followed, OP colonoscopy.  4. Thrombocytopenia: Platelets normal at baseline.  Platelets 142 on admit.  Likely due to above.  monitored, stable. 5. Demand ischemia, Elevated troponin: Troponin 69 on admit.  Repeat troponin stable.  EKG on admit nonacute.  No further work-up 6. COPD with chronic respiratory failure: On 2 to 3 L nasal cannula at baseline.  No evidence of exacerbation.  Continue home inhalers.  Continue home oxygen 7. ESRD: Follows with Dr. (nephrology).  On HD Monday Wednesday and Friday.  Consulted nephrology for ESRD while inpatient 8. Chronic systolic CHF: Follows with Dr. (MC).  TTE 3/23 with EF of 40%.  Volume management per HD. 9. Paroxysmal atrial fibrillation: Eliquis held dt bloody BM, restarted. no longer on beta-blocker due to hypotension 10. IDDM2: Follows with Dr. (endocrinology).  On U-500 at home.  Recent hospitalization for hypoglycemia and insulin adjusted.  Continued home U-500.  Endocrine followed, adjusted regimen as below.  11. Anemia of chronic disease: Baseline hemoglobin 8-9.  Hemoglobin 7.9 on admit. Stable.  12. Chronic liver disease: Follows with Dr. (GI).  S/p biopsy 5/20/2022 with perisinusoidal fibrosis.  Continue home lactulose and Xifaxan. 13. Recent right ankle fracture: S/p ORIF 8/24/2023 by Dr. (ortho). 14. Chronic pain: NaRx reviewed on admit.  Continued home medications 15. Obesity: BMI 37
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Echocardiogram abnormal, Ejection fraction decreased, Electrocardiogram normal, Haematochezia
Clinical narrative: Patient is a 63 y.o. female with a history of IDDM2 on U-500, Afib on Eliquis, chronic systolic CHF, ESRD on HD, and multiple recent hospital admists 8/11-8/21/23 for acute CHF and started on HD, 8/23-9/2/23 for R ankle fracture s/p ORIF and 9/15-9/20/23 for hypoglycemia and discharged home with HHC. She presented to hospital 9/23/2023 with 1 day history of fever, dyspnea and cough and was found to have COVID 19. Course complicated by Bifidobacterium bacteremia.    1. COVID 19: 1 day history of fever, productive cough and shortness of breath.  COVID-19 positive on admit.  Chest x-ray on admit nonacute.  Patient on baseline oxygen requirement.  ID followed, remdesivir thru 9/29/23.  2. Bifidobacterium bacteremia: 1/2 bottle from 9/23/23. Started on unasyn 9/25/23. Repeat blood cx 9/25/23, negative so far. ID followed, recommended CT Ab/pelvis which was non acute, and Unasyn continued thru 9/29/23. 3. Nausea, diarrhea, Bloody stools: C diff neg. Eliquis held, restarted 9/29/23. Zofran, PPI ordered. GI followed, OP colonoscopy.  4. Thrombocytopenia: Platelets normal at baseline.  Platelets 142 on admit.  Likely due to above.  monitored, stable. 5. Demand ischemia, Elevated troponin: Troponin 69 on admit.  Repeat troponin stable.  EKG on admit nonacute.  No further work-up 6. COPD with chronic respiratory failure: On 2 to 3 L nasal cannula at baseline.  No evidence of exacerbation.  Continue home inhalers.  Continue home oxygen 7. ESRD: Follows with Dr. (nephrology).  On HD Monday Wednesday and Friday.  Consulted nephrology for ESRD while inpatient 8. Chronic systolic CHF: Follows with Dr. (MC).  TTE 3/23 with EF of 40%.  Volume management per HD. 9. Paroxysmal atrial fibrillation: Eliquis held dt bloody BM, restarted. no longer on beta-blocker due to hypotension 10. IDDM2: Follows with Dr. (endocrinology).  On U-500 at home.  Recent hospitalization for hypoglycemia and insulin adjusted.  Continued home U-500.  Endocrine followed, adjusted regimen as below.  11. Anemia of chronic disease: Baseline hemoglobin 8-9.  Hemoglobin 7.9 on admit. Stable.  12. Chronic liver disease: Follows with Dr. (GI).  S/p biopsy 5/20/2022 with perisinusoidal fibrosis.  Continue home lactulose and Xifaxan. 13. Recent right ankle fracture: S/p ORIF 8/24/2023 by Dr. (ortho). 14. Chronic pain: NaRx reviewed on admit.  Continued home medications 15. Obesity: BMI 37
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Haemodialysis, Haemoglobin decreased, Hepatic fibrosis, Hypoglycaemia, Hypotension
Clinical narrative: Patient is a 63 y.o. female with a history of IDDM2 on U-500, Afib on Eliquis, chronic systolic CHF, ESRD on HD, and multiple recent hospital admists 8/11-8/21/23 for acute CHF and started on HD, 8/23-9/2/23 for R ankle fracture s/p ORIF and 9/15-9/20/23 for hypoglycemia and discharged home with HHC. She presented to hospital 9/23/2023 with 1 day history of fever, dyspnea and cough and was found to have COVID 19. Course complicated by Bifidobacterium bacteremia.    1. COVID 19: 1 day history of fever, productive cough and shortness of breath.  COVID-19 positive on admit.  Chest x-ray on admit nonacute.  Patient on baseline oxygen requirement.  ID followed, remdesivir thru 9/29/23.  2. Bifidobacterium bacteremia: 1/2 bottle from 9/23/23. Started on unasyn 9/25/23. Repeat blood cx 9/25/23, negative so far. ID followed, recommended CT Ab/pelvis which was non acute, and Unasyn continued thru 9/29/23. 3. Nausea, diarrhea, Bloody stools: C diff neg. Eliquis held, restarted 9/29/23. Zofran, PPI ordered. GI followed, OP colonoscopy.  4. Thrombocytopenia: Platelets normal at baseline.  Platelets 142 on admit.  Likely due to above.  monitored, stable. 5. Demand ischemia, Elevated troponin: Troponin 69 on admit.  Repeat troponin stable.  EKG on admit nonacute.  No further work-up 6. COPD with chronic respiratory failure: On 2 to 3 L nasal cannula at baseline.  No evidence of exacerbation.  Continue home inhalers.  Continue home oxygen 7. ESRD: Follows with Dr. (nephrology).  On HD Monday Wednesday and Friday.  Consulted nephrology for ESRD while inpatient 8. Chronic systolic CHF: Follows with Dr. (MC).  TTE 3/23 with EF of 40%.  Volume management per HD. 9. Paroxysmal atrial fibrillation: Eliquis held dt bloody BM, restarted. no longer on beta-blocker due to hypotension 10. IDDM2: Follows with Dr. (endocrinology).  On U-500 at home.  Recent hospitalization for hypoglycemia and insulin adjusted.  Continued home U-500.  Endocrine followed, adjusted regimen as below.  11. Anemia of chronic disease: Baseline hemoglobin 8-9.  Hemoglobin 7.9 on admit. Stable.  12. Chronic liver disease: Follows with Dr. (GI).  S/p biopsy 5/20/2022 with perisinusoidal fibrosis.  Continue home lactulose and Xifaxan. 13. Recent right ankle fracture: S/p ORIF 8/24/2023 by Dr. (ortho). 14. Chronic pain: NaRx reviewed on admit.  Continued home medications 15. Obesity: BMI 37
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Myocardial ischaemia, Nausea, Open reduction of fracture, Platelet count decreased, Productive cough
Clinical narrative: Patient is a 63 y.o. female with a history of IDDM2 on U-500, Afib on Eliquis, chronic systolic CHF, ESRD on HD, and multiple recent hospital admists 8/11-8/21/23 for acute CHF and started on HD, 8/23-9/2/23 for R ankle fracture s/p ORIF and 9/15-9/20/23 for hypoglycemia and discharged home with HHC. She presented to hospital 9/23/2023 with 1 day history of fever, dyspnea and cough and was found to have COVID 19. Course complicated by Bifidobacterium bacteremia.    1. COVID 19: 1 day history of fever, productive cough and shortness of breath.  COVID-19 positive on admit.  Chest x-ray on admit nonacute.  Patient on baseline oxygen requirement.  ID followed, remdesivir thru 9/29/23.  2. Bifidobacterium bacteremia: 1/2 bottle from 9/23/23. Started on unasyn 9/25/23. Repeat blood cx 9/25/23, negative so far. ID followed, recommended CT Ab/pelvis which was non acute, and Unasyn continued thru 9/29/23. 3. Nausea, diarrhea, Bloody stools: C diff neg. Eliquis held, restarted 9/29/23. Zofran, PPI ordered. GI followed, OP colonoscopy.  4. Thrombocytopenia: Platelets normal at baseline.  Platelets 142 on admit.  Likely due to above.  monitored, stable. 5. Demand ischemia, Elevated troponin: Troponin 69 on admit.  Repeat troponin stable.  EKG on admit nonacute.  No further work-up 6. COPD with chronic respiratory failure: On 2 to 3 L nasal cannula at baseline.  No evidence of exacerbation.  Continue home inhalers.  Continue home oxygen 7. ESRD: Follows with Dr. (nephrology).  On HD Monday Wednesday and Friday.  Consulted nephrology for ESRD while inpatient 8. Chronic systolic CHF: Follows with Dr. (MC).  TTE 3/23 with EF of 40%.  Volume management per HD. 9. Paroxysmal atrial fibrillation: Eliquis held dt bloody BM, restarted. no longer on beta-blocker due to hypotension 10. IDDM2: Follows with Dr. (endocrinology).  On U-500 at home.  Recent hospitalization for hypoglycemia and insulin adjusted.  Continued home U-500.  Endocrine followed, adjusted regimen as below.  11. Anemia of chronic disease: Baseline hemoglobin 8-9.  Hemoglobin 7.9 on admit. Stable.  12. Chronic liver disease: Follows with Dr. (GI).  S/p biopsy 5/20/2022 with perisinusoidal fibrosis.  Continue home lactulose and Xifaxan. 13. Recent right ankle fracture: S/p ORIF 8/24/2023 by Dr. (ortho). 14. Chronic pain: NaRx reviewed on admit.  Continued home medications 15. Obesity: BMI 37
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Thrombocytopenia, Troponin increased
Clinical narrative: Patient is a 63 y.o. female with a history of IDDM2 on U-500, Afib on Eliquis, chronic systolic CHF, ESRD on HD, and multiple recent hospital admists 8/11-8/21/23 for acute CHF and started on HD, 8/23-9/2/23 for R ankle fracture s/p ORIF and 9/15-9/20/23 for hypoglycemia and discharged home with HHC. She presented to hospital 9/23/2023 with 1 day history of fever, dyspnea and cough and was found to have COVID 19. Course complicated by Bifidobacterium bacteremia.    1. COVID 19: 1 day history of fever, productive cough and shortness of breath.  COVID-19 positive on admit.  Chest x-ray on admit nonacute.  Patient on baseline oxygen requirement.  ID followed, remdesivir thru 9/29/23.  2. Bifidobacterium bacteremia: 1/2 bottle from 9/23/23. Started on unasyn 9/25/23. Repeat blood cx 9/25/23, negative so far. ID followed, recommended CT Ab/pelvis which was non acute, and Unasyn continued thru 9/29/23. 3. Nausea, diarrhea, Bloody stools: C diff neg. Eliquis held, restarted 9/29/23. Zofran, PPI ordered. GI followed, OP colonoscopy.  4. Thrombocytopenia: Platelets normal at baseline.  Platelets 142 on admit.  Likely due to above.  monitored, stable. 5. Demand ischemia, Elevated troponin: Troponin 69 on admit.  Repeat troponin stable.  EKG on admit nonacute.  No further work-up 6. COPD with chronic respiratory failure: On 2 to 3 L nasal cannula at baseline.  No evidence of exacerbation.  Continue home inhalers.  Continue home oxygen 7. ESRD: Follows with Dr. (nephrology).  On HD Monday Wednesday and Friday.  Consulted nephrology for ESRD while inpatient 8. Chronic systolic CHF: Follows with Dr. (MC).  TTE 3/23 with EF of 40%.  Volume management per HD. 9. Paroxysmal atrial fibrillation: Eliquis held dt bloody BM, restarted. no longer on beta-blocker due to hypotension 10. IDDM2: Follows with Dr. (endocrinology).  On U-500 at home.  Recent hospitalization for hypoglycemia and insulin adjusted.  Continued home U-500.  Endocrine followed, adjusted regimen as below.  11. Anemia of chronic disease: Baseline hemoglobin 8-9.  Hemoglobin 7.9 on admit. Stable.  12. Chronic liver disease: Follows with Dr. (GI).  S/p biopsy 5/20/2022 with perisinusoidal fibrosis.  Continue home lactulose and Xifaxan. 13. Recent right ankle fracture: S/p ORIF 8/24/2023 by Dr. (ortho). 14. Chronic pain: NaRx reviewed on admit.  Continued home medications 15. Obesity: BMI 37
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS  STORED IN AN UNAPPROVED STORAGE UNIT
Age: 11.0
Sex: F
Vaccine: FLU4, HPV9, MNQ, TDAP
Symptoms: Cold sweat, Presyncope, Seizure, Somnolence
Clinical narrative: After administering last immunization, Tdap, Meningococcal, HPV and Flu shot, approx. 1 minute later patient convulsed and made snorting noise lasting approx. 15sec. Grandmother states patients father does the same thing after injections. Grandmother states patient does not have history of seizures or family history. Patients skin cool and clammy and could not keep eyes open for 15 seconds. Patient aware of surroundings, but drowsy for 3 minutes. Normal respirations, pulse. Offered to call ambulance transfer to ED. Declined by grandmother. Advised grandmother to seek further medical attention if needed. Assisted patient to personal vehicle in wheel chair, Patient stable and alert when leaving health unit. Grandmother states she was taking patient to ED. 1600 TC from patient grandmother stating patient was seen in ER and released, ER stated patient had vasovagal reaction from immunizations.
Age: 91.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Angiogram cerebral abnormal, Angiogram pulmonary abnormal, Anticoagulant therapy, Asthenia
Clinical narrative: Patient is a 92 y.o. female with a history of permanent afib, HFpEF, Hypothyroidism who presented to hospital 9/11/2023 with weakness, fever and malaise. Covid-19 positive, troponin 48, ntpro 2821. Hospitalization complicated by Afib with RVR. CTPA on admission with bilateral pleural effusions, treated with IV diuresis.   1. Acute hypoxemic respiratory failure: required 2L NC on admit. Multifactorial due to cardiogenic pulmonary edema and covid-19. Weaned to RA at discharge. 2. COVID-19 infection: symptom onset 9/9/23. Positive on admit. Steroids, remdesivir in house, no indication for continuation at discharge. 3. Permanent Atrial fibrillation with RVR: per history, afib on admit. Continued home coumadin. Dilt drip transitioned to PO then d/ced with bradycardia. Titrated home BB, f/u with PCP. 4. Acute decompensated heart failure with preserved EF: known history. EF 55-60% 2019. Ntpro 2821 with pleural effusion as above. IV lasix for diuresis, PO transition 9/16/23. F/u with PCP for lab monitoring, further titration 5. Mitral valve regurgitation: per history, s/p bioprosthetic valve replacement. 6. Tricuspid regurgitation: per history.  7. Right ICA stenosis: noted on cta head on admit with 87% stenosis on right ICA. Continued coumadin. 8. Incidental findings: simple cyst in left kidney and stable low density lesions in liver that are stable on CT. 9. Code status: DNRCC, confirmed with daughter, HCPOA on admit.
Age: 91.0
Sex: F
Vaccine: COVID19-2
Symptoms: Atrial fibrillation, Bradycardia, COVID-19, Carotid artery stenosis, Computerised tomogram abdomen abnormal
Clinical narrative: Patient is a 92 y.o. female with a history of permanent afib, HFpEF, Hypothyroidism who presented to hospital 9/11/2023 with weakness, fever and malaise. Covid-19 positive, troponin 48, ntpro 2821. Hospitalization complicated by Afib with RVR. CTPA on admission with bilateral pleural effusions, treated with IV diuresis.   1. Acute hypoxemic respiratory failure: required 2L NC on admit. Multifactorial due to cardiogenic pulmonary edema and covid-19. Weaned to RA at discharge. 2. COVID-19 infection: symptom onset 9/9/23. Positive on admit. Steroids, remdesivir in house, no indication for continuation at discharge. 3. Permanent Atrial fibrillation with RVR: per history, afib on admit. Continued home coumadin. Dilt drip transitioned to PO then d/ced with bradycardia. Titrated home BB, f/u with PCP. 4. Acute decompensated heart failure with preserved EF: known history. EF 55-60% 2019. Ntpro 2821 with pleural effusion as above. IV lasix for diuresis, PO transition 9/16/23. F/u with PCP for lab monitoring, further titration 5. Mitral valve regurgitation: per history, s/p bioprosthetic valve replacement. 6. Tricuspid regurgitation: per history.  7. Right ICA stenosis: noted on cta head on admit with 87% stenosis on right ICA. Continued coumadin. 8. Incidental findings: simple cyst in left kidney and stable low density lesions in liver that are stable on CT. 9. Code status: DNRCC, confirmed with daughter, HCPOA on admit.
Age: 91.0
Sex: F
Vaccine: COVID19-2
Symptoms: Condition aggravated, Diuretic therapy, Hepatic lesion, Malaise, N-terminal prohormone brain natriuretic peptide increased
Clinical narrative: Patient is a 92 y.o. female with a history of permanent afib, HFpEF, Hypothyroidism who presented to hospital 9/11/2023 with weakness, fever and malaise. Covid-19 positive, troponin 48, ntpro 2821. Hospitalization complicated by Afib with RVR. CTPA on admission with bilateral pleural effusions, treated with IV diuresis.   1. Acute hypoxemic respiratory failure: required 2L NC on admit. Multifactorial due to cardiogenic pulmonary edema and covid-19. Weaned to RA at discharge. 2. COVID-19 infection: symptom onset 9/9/23. Positive on admit. Steroids, remdesivir in house, no indication for continuation at discharge. 3. Permanent Atrial fibrillation with RVR: per history, afib on admit. Continued home coumadin. Dilt drip transitioned to PO then d/ced with bradycardia. Titrated home BB, f/u with PCP. 4. Acute decompensated heart failure with preserved EF: known history. EF 55-60% 2019. Ntpro 2821 with pleural effusion as above. IV lasix for diuresis, PO transition 9/16/23. F/u with PCP for lab monitoring, further titration 5. Mitral valve regurgitation: per history, s/p bioprosthetic valve replacement. 6. Tricuspid regurgitation: per history.  7. Right ICA stenosis: noted on cta head on admit with 87% stenosis on right ICA. Continued coumadin. 8. Incidental findings: simple cyst in left kidney and stable low density lesions in liver that are stable on CT. 9. Code status: DNRCC, confirmed with daughter, HCPOA on admit.
Age: 91.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pleural effusion, Pulmonary oedema, Pyrexia, Renal cyst, SARS-CoV-2 test positive
Clinical narrative: Patient is a 92 y.o. female with a history of permanent afib, HFpEF, Hypothyroidism who presented to hospital 9/11/2023 with weakness, fever and malaise. Covid-19 positive, troponin 48, ntpro 2821. Hospitalization complicated by Afib with RVR. CTPA on admission with bilateral pleural effusions, treated with IV diuresis.   1. Acute hypoxemic respiratory failure: required 2L NC on admit. Multifactorial due to cardiogenic pulmonary edema and covid-19. Weaned to RA at discharge. 2. COVID-19 infection: symptom onset 9/9/23. Positive on admit. Steroids, remdesivir in house, no indication for continuation at discharge. 3. Permanent Atrial fibrillation with RVR: per history, afib on admit. Continued home coumadin. Dilt drip transitioned to PO then d/ced with bradycardia. Titrated home BB, f/u with PCP. 4. Acute decompensated heart failure with preserved EF: known history. EF 55-60% 2019. Ntpro 2821 with pleural effusion as above. IV lasix for diuresis, PO transition 9/16/23. F/u with PCP for lab monitoring, further titration 5. Mitral valve regurgitation: per history, s/p bioprosthetic valve replacement. 6. Tricuspid regurgitation: per history.  7. Right ICA stenosis: noted on cta head on admit with 87% stenosis on right ICA. Continued coumadin. 8. Incidental findings: simple cyst in left kidney and stable low density lesions in liver that are stable on CT. 9. Code status: DNRCC, confirmed with daughter, HCPOA on admit.
Age: 91.0
Sex: F
Vaccine: COVID19-2
Symptoms: Troponin increased
Clinical narrative: Patient is a 92 y.o. female with a history of permanent afib, HFpEF, Hypothyroidism who presented to hospital 9/11/2023 with weakness, fever and malaise. Covid-19 positive, troponin 48, ntpro 2821. Hospitalization complicated by Afib with RVR. CTPA on admission with bilateral pleural effusions, treated with IV diuresis.   1. Acute hypoxemic respiratory failure: required 2L NC on admit. Multifactorial due to cardiogenic pulmonary edema and covid-19. Weaned to RA at discharge. 2. COVID-19 infection: symptom onset 9/9/23. Positive on admit. Steroids, remdesivir in house, no indication for continuation at discharge. 3. Permanent Atrial fibrillation with RVR: per history, afib on admit. Continued home coumadin. Dilt drip transitioned to PO then d/ced with bradycardia. Titrated home BB, f/u with PCP. 4. Acute decompensated heart failure with preserved EF: known history. EF 55-60% 2019. Ntpro 2821 with pleural effusion as above. IV lasix for diuresis, PO transition 9/16/23. F/u with PCP for lab monitoring, further titration 5. Mitral valve regurgitation: per history, s/p bioprosthetic valve replacement. 6. Tricuspid regurgitation: per history.  7. Right ICA stenosis: noted on cta head on admit with 87% stenosis on right ICA. Continued coumadin. 8. Incidental findings: simple cyst in left kidney and stable low density lesions in liver that are stable on CT. 9. Code status: DNRCC, confirmed with daughter, HCPOA on admit.
Age: 74.0
Sex: F
Vaccine: COVID19, RSV
Symptoms: Injection site reaction, Injection site swelling, Injection site warmth, Rash erythematous, Urticaria
Clinical narrative: Patient developed a large red welt that was warm to the touch and caused swelling at the site of injection. It is over 2 weeks later and the swelling has gone down but there is a unraised red rash that still remains.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Atrial flutter, Cardiac ablation, Dyspnoea, Electrocardiogram abnormal
Clinical narrative: shortness of breath, weakness, fatigue, racing heartbeat within 2 days of vaccine (previous vaccines were Pfeiser, this one was Moderna)
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Palpitations
Clinical narrative: shortness of breath, weakness, fatigue, racing heartbeat within 2 days of vaccine (previous vaccines were Pfeiser, this one was Moderna)
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS  STORED IN AN UNAPPROVED STORAGE UNIT
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute myocardial infarction, Acute respiratory failure, Anticoagulant therapy, Bladder catheterisation
Clinical narrative: Patient is a 80 y.o. male patient of MD with a PMHx of CAD s/p CABG, HFpEF, cAF, HTN, HLD, T2DM, GERD presented to hospital for malaise/cough and transferred for elevated troponin.   COVID-19 infection  Acute hypoxemic respiratory failure dt above  P/t hospital with malaise, fatigue, non-productive cough. Transferred for elevated troponin in setting of AKI on CKD. Afebrile on arrival, HDS. No hypoxia Initial CBC without leukocytosis CXR: normal Did not meet criteria for remdesivir/decadron on admission however given interval development of respiratory failure will initiate decadron 6mg daily x 10d  CRP mildly elevated on admission S/p 1x dose IV lasix, resume PO lasix today  Off oxygen, not hypoxemic with exertion today  Discharge home to complete decadron course   Troponinemia, likely type 2 NSTEMI from AKI on CKD CAD s/p CABG, PCI cAF on Eliquis HTN, HLD HFpEF; compensated Denies chest pain or anginal equivalents. Recent normal ischemic work up Initial troponin 66, repeats 56, 54 with negative delta.  Recent stress MPI in 7/2023 without reversible ischemia Recent echo 7/2023 with EF 63%, mod-severe LVH. No WM Repeat EKG unchanged from prior.  Cont home amiodarone, Plavix, statin,Eliquis, Imdur, Toprol AKI on CKD Hx of BPH  Acute urinary retention  Initial Cr 2.1 (recent baseline ~1.7-1.9). Does not appear to follow with nephrology Presumably prerenal from poor PO intake w/ COVID in setting of Lasix/ACEi. Probable underlying diabetic nephropathy Renal/bladder US: multiple cysts on R.  Bladder distended.  PO lasix and lisinopril on hold, will give 1x dose IV lasix today and resume PO lasix in AM   Continue to hold lisinopril for now  Foley placed d/t urinary retention on admission, failed voiding trial.  Foley replaced  Urology referral on discharge for outpatient voiding trial.    Thrombocytopenia  Likely d/t ongoing infectious process, hgb stable, low concern for hemolytic process  Currently 129, CTM closely Transfuse for platelets < 10k    T2DM, poor controlled A1c 8.7%  Home regimen: Levimir 20 units BID, Aspart 10 units qAC with SSI Dose reduce Lantus 16u BID, Aspart 8u qAC with SSI Hypoglycemic protocol. Hold home oral meds
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Bladder cyst, Bladder dilatation, C-reactive protein increased, COVID-19, Chest X-ray normal
Clinical narrative: Patient is a 80 y.o. male patient of MD with a PMHx of CAD s/p CABG, HFpEF, cAF, HTN, HLD, T2DM, GERD presented to hospital for malaise/cough and transferred for elevated troponin.   COVID-19 infection  Acute hypoxemic respiratory failure dt above  P/t hospital with malaise, fatigue, non-productive cough. Transferred for elevated troponin in setting of AKI on CKD. Afebrile on arrival, HDS. No hypoxia Initial CBC without leukocytosis CXR: normal Did not meet criteria for remdesivir/decadron on admission however given interval development of respiratory failure will initiate decadron 6mg daily x 10d  CRP mildly elevated on admission S/p 1x dose IV lasix, resume PO lasix today  Off oxygen, not hypoxemic with exertion today  Discharge home to complete decadron course   Troponinemia, likely type 2 NSTEMI from AKI on CKD CAD s/p CABG, PCI cAF on Eliquis HTN, HLD HFpEF; compensated Denies chest pain or anginal equivalents. Recent normal ischemic work up Initial troponin 66, repeats 56, 54 with negative delta.  Recent stress MPI in 7/2023 without reversible ischemia Recent echo 7/2023 with EF 63%, mod-severe LVH. No WM Repeat EKG unchanged from prior.  Cont home amiodarone, Plavix, statin,Eliquis, Imdur, Toprol AKI on CKD Hx of BPH  Acute urinary retention  Initial Cr 2.1 (recent baseline ~1.7-1.9). Does not appear to follow with nephrology Presumably prerenal from poor PO intake w/ COVID in setting of Lasix/ACEi. Probable underlying diabetic nephropathy Renal/bladder US: multiple cysts on R.  Bladder distended.  PO lasix and lisinopril on hold, will give 1x dose IV lasix today and resume PO lasix in AM   Continue to hold lisinopril for now  Foley placed d/t urinary retention on admission, failed voiding trial.  Foley replaced  Urology referral on discharge for outpatient voiding trial.    Thrombocytopenia  Likely d/t ongoing infectious process, hgb stable, low concern for hemolytic process  Currently 129, CTM closely Transfuse for platelets < 10k    T2DM, poor controlled A1c 8.7%  Home regimen: Levimir 20 units BID, Aspart 10 units qAC with SSI Dose reduce Lantus 16u BID, Aspart 8u qAC with SSI Hypoglycemic protocol. Hold home oral meds
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Diabetic nephropathy, Echocardiogram abnormal, Electrocardiogram, Fatigue
Clinical narrative: Patient is a 80 y.o. male patient of MD with a PMHx of CAD s/p CABG, HFpEF, cAF, HTN, HLD, T2DM, GERD presented to hospital for malaise/cough and transferred for elevated troponin.   COVID-19 infection  Acute hypoxemic respiratory failure dt above  P/t hospital with malaise, fatigue, non-productive cough. Transferred for elevated troponin in setting of AKI on CKD. Afebrile on arrival, HDS. No hypoxia Initial CBC without leukocytosis CXR: normal Did not meet criteria for remdesivir/decadron on admission however given interval development of respiratory failure will initiate decadron 6mg daily x 10d  CRP mildly elevated on admission S/p 1x dose IV lasix, resume PO lasix today  Off oxygen, not hypoxemic with exertion today  Discharge home to complete decadron course   Troponinemia, likely type 2 NSTEMI from AKI on CKD CAD s/p CABG, PCI cAF on Eliquis HTN, HLD HFpEF; compensated Denies chest pain or anginal equivalents. Recent normal ischemic work up Initial troponin 66, repeats 56, 54 with negative delta.  Recent stress MPI in 7/2023 without reversible ischemia Recent echo 7/2023 with EF 63%, mod-severe LVH. No WM Repeat EKG unchanged from prior.  Cont home amiodarone, Plavix, statin,Eliquis, Imdur, Toprol AKI on CKD Hx of BPH  Acute urinary retention  Initial Cr 2.1 (recent baseline ~1.7-1.9). Does not appear to follow with nephrology Presumably prerenal from poor PO intake w/ COVID in setting of Lasix/ACEi. Probable underlying diabetic nephropathy Renal/bladder US: multiple cysts on R.  Bladder distended.  PO lasix and lisinopril on hold, will give 1x dose IV lasix today and resume PO lasix in AM   Continue to hold lisinopril for now  Foley placed d/t urinary retention on admission, failed voiding trial.  Foley replaced  Urology referral on discharge for outpatient voiding trial.    Thrombocytopenia  Likely d/t ongoing infectious process, hgb stable, low concern for hemolytic process  Currently 129, CTM closely Transfuse for platelets < 10k    T2DM, poor controlled A1c 8.7%  Home regimen: Levimir 20 units BID, Aspart 10 units qAC with SSI Dose reduce Lantus 16u BID, Aspart 8u qAC with SSI Hypoglycemic protocol. Hold home oral meds
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count normal, Glycosylated haemoglobin increased, Haemoglobin, Left ventricular hypertrophy, Malaise
Clinical narrative: Patient is a 80 y.o. male patient of MD with a PMHx of CAD s/p CABG, HFpEF, cAF, HTN, HLD, T2DM, GERD presented to hospital for malaise/cough and transferred for elevated troponin.   COVID-19 infection  Acute hypoxemic respiratory failure dt above  P/t hospital with malaise, fatigue, non-productive cough. Transferred for elevated troponin in setting of AKI on CKD. Afebrile on arrival, HDS. No hypoxia Initial CBC without leukocytosis CXR: normal Did not meet criteria for remdesivir/decadron on admission however given interval development of respiratory failure will initiate decadron 6mg daily x 10d  CRP mildly elevated on admission S/p 1x dose IV lasix, resume PO lasix today  Off oxygen, not hypoxemic with exertion today  Discharge home to complete decadron course   Troponinemia, likely type 2 NSTEMI from AKI on CKD CAD s/p CABG, PCI cAF on Eliquis HTN, HLD HFpEF; compensated Denies chest pain or anginal equivalents. Recent normal ischemic work up Initial troponin 66, repeats 56, 54 with negative delta.  Recent stress MPI in 7/2023 without reversible ischemia Recent echo 7/2023 with EF 63%, mod-severe LVH. No WM Repeat EKG unchanged from prior.  Cont home amiodarone, Plavix, statin,Eliquis, Imdur, Toprol AKI on CKD Hx of BPH  Acute urinary retention  Initial Cr 2.1 (recent baseline ~1.7-1.9). Does not appear to follow with nephrology Presumably prerenal from poor PO intake w/ COVID in setting of Lasix/ACEi. Probable underlying diabetic nephropathy Renal/bladder US: multiple cysts on R.  Bladder distended.  PO lasix and lisinopril on hold, will give 1x dose IV lasix today and resume PO lasix in AM   Continue to hold lisinopril for now  Foley placed d/t urinary retention on admission, failed voiding trial.  Foley replaced  Urology referral on discharge for outpatient voiding trial.    Thrombocytopenia  Likely d/t ongoing infectious process, hgb stable, low concern for hemolytic process  Currently 129, CTM closely Transfuse for platelets < 10k    T2DM, poor controlled A1c 8.7%  Home regimen: Levimir 20 units BID, Aspart 10 units qAC with SSI Dose reduce Lantus 16u BID, Aspart 8u qAC with SSI Hypoglycemic protocol. Hold home oral meds
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory failure, Scan myocardial perfusion, Thrombocytopenia, Trial of void, Troponin increased
Clinical narrative: Patient is a 80 y.o. male patient of MD with a PMHx of CAD s/p CABG, HFpEF, cAF, HTN, HLD, T2DM, GERD presented to hospital for malaise/cough and transferred for elevated troponin.   COVID-19 infection  Acute hypoxemic respiratory failure dt above  P/t hospital with malaise, fatigue, non-productive cough. Transferred for elevated troponin in setting of AKI on CKD. Afebrile on arrival, HDS. No hypoxia Initial CBC without leukocytosis CXR: normal Did not meet criteria for remdesivir/decadron on admission however given interval development of respiratory failure will initiate decadron 6mg daily x 10d  CRP mildly elevated on admission S/p 1x dose IV lasix, resume PO lasix today  Off oxygen, not hypoxemic with exertion today  Discharge home to complete decadron course   Troponinemia, likely type 2 NSTEMI from AKI on CKD CAD s/p CABG, PCI cAF on Eliquis HTN, HLD HFpEF; compensated Denies chest pain or anginal equivalents. Recent normal ischemic work up Initial troponin 66, repeats 56, 54 with negative delta.  Recent stress MPI in 7/2023 without reversible ischemia Recent echo 7/2023 with EF 63%, mod-severe LVH. No WM Repeat EKG unchanged from prior.  Cont home amiodarone, Plavix, statin,Eliquis, Imdur, Toprol AKI on CKD Hx of BPH  Acute urinary retention  Initial Cr 2.1 (recent baseline ~1.7-1.9). Does not appear to follow with nephrology Presumably prerenal from poor PO intake w/ COVID in setting of Lasix/ACEi. Probable underlying diabetic nephropathy Renal/bladder US: multiple cysts on R.  Bladder distended.  PO lasix and lisinopril on hold, will give 1x dose IV lasix today and resume PO lasix in AM   Continue to hold lisinopril for now  Foley placed d/t urinary retention on admission, failed voiding trial.  Foley replaced  Urology referral on discharge for outpatient voiding trial.    Thrombocytopenia  Likely d/t ongoing infectious process, hgb stable, low concern for hemolytic process  Currently 129, CTM closely Transfuse for platelets < 10k    T2DM, poor controlled A1c 8.7%  Home regimen: Levimir 20 units BID, Aspart 10 units qAC with SSI Dose reduce Lantus 16u BID, Aspart 8u qAC with SSI Hypoglycemic protocol. Hold home oral meds
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Ultrasound bladder abnormal, Urinary retention
Clinical narrative: Patient is a 80 y.o. male patient of MD with a PMHx of CAD s/p CABG, HFpEF, cAF, HTN, HLD, T2DM, GERD presented to hospital for malaise/cough and transferred for elevated troponin.   COVID-19 infection  Acute hypoxemic respiratory failure dt above  P/t hospital with malaise, fatigue, non-productive cough. Transferred for elevated troponin in setting of AKI on CKD. Afebrile on arrival, HDS. No hypoxia Initial CBC without leukocytosis CXR: normal Did not meet criteria for remdesivir/decadron on admission however given interval development of respiratory failure will initiate decadron 6mg daily x 10d  CRP mildly elevated on admission S/p 1x dose IV lasix, resume PO lasix today  Off oxygen, not hypoxemic with exertion today  Discharge home to complete decadron course   Troponinemia, likely type 2 NSTEMI from AKI on CKD CAD s/p CABG, PCI cAF on Eliquis HTN, HLD HFpEF; compensated Denies chest pain or anginal equivalents. Recent normal ischemic work up Initial troponin 66, repeats 56, 54 with negative delta.  Recent stress MPI in 7/2023 without reversible ischemia Recent echo 7/2023 with EF 63%, mod-severe LVH. No WM Repeat EKG unchanged from prior.  Cont home amiodarone, Plavix, statin,Eliquis, Imdur, Toprol AKI on CKD Hx of BPH  Acute urinary retention  Initial Cr 2.1 (recent baseline ~1.7-1.9). Does not appear to follow with nephrology Presumably prerenal from poor PO intake w/ COVID in setting of Lasix/ACEi. Probable underlying diabetic nephropathy Renal/bladder US: multiple cysts on R.  Bladder distended.  PO lasix and lisinopril on hold, will give 1x dose IV lasix today and resume PO lasix in AM   Continue to hold lisinopril for now  Foley placed d/t urinary retention on admission, failed voiding trial.  Foley replaced  Urology referral on discharge for outpatient voiding trial.    Thrombocytopenia  Likely d/t ongoing infectious process, hgb stable, low concern for hemolytic process  Currently 129, CTM closely Transfuse for platelets < 10k    T2DM, poor controlled A1c 8.7%  Home regimen: Levimir 20 units BID, Aspart 10 units qAC with SSI Dose reduce Lantus 16u BID, Aspart 8u qAC with SSI Hypoglycemic protocol. Hold home oral meds
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Heart rate increased
Clinical narrative: I received the vaccine at 9:00am on October 15th.   Early in the morning on October 16th, I had chest pains and rapid heartbeat.
Age: 30.0
Sex: F
Vaccine: COVID19, FLUC4
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: Red spot, warm to touch, sore with pressure
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Patient had a red swollen painful area appear on her arm underneath the injection site. On the 16th the redness started to subside and come that night she was able to sleep on that arm
Age: 61.0
Sex: M
Vaccine: RSV
Symptoms: Burning sensation, Cardiac monitoring, Chest X-ray, Chest pain, Dyspnoea
Clinical narrative: Just after two weeks of receiving the RSV vaccine I had an incident happen at my home with a possible reaction to the vaccine. after cleaning my bathroom floor with a strong solution of pine cleaner I experienced a strong burning in my lungs and rapid heartbeat for a short time. I waited until the following Sunday to go to the Urgent Care (I thought it might get better with time but didn't) with shortness of breath, lung/chest pain, the feeling of inadequate oxygen intake, etc. was then (the same day) transferred to ER for chest x-ray and heart monitoring, then released six hours later. I had a follow up this morning at Dr office and told them of my continuing lung problems and have been prescribed steroids with follow up chest ultrasound yet to be scheduled. Note: I've used pine cleaners for years and never had such an intense reaction before. I've since read about possible lung inflammation from the RSV vaccine and wondered if the vaccine might have inflamed my lung tissues and greatly magnified my reaction. I was told by one medical provider that it might be chemically induced bronchitis. If you all receive any reports of chemically induced bronchitis or pneumonia from recently RSV vaccinated patients, please research a possible adverse reaction connection. Thank you!
Age: 61.0
Sex: M
Vaccine: RSV
Symptoms: Exposure to household chemicals, Heart rate increased, Pulmonary pain, Sensory disturbance
Clinical narrative: Just after two weeks of receiving the RSV vaccine I had an incident happen at my home with a possible reaction to the vaccine. after cleaning my bathroom floor with a strong solution of pine cleaner I experienced a strong burning in my lungs and rapid heartbeat for a short time. I waited until the following Sunday to go to the Urgent Care (I thought it might get better with time but didn't) with shortness of breath, lung/chest pain, the feeling of inadequate oxygen intake, etc. was then (the same day) transferred to ER for chest x-ray and heart monitoring, then released six hours later. I had a follow up this morning at Dr office and told them of my continuing lung problems and have been prescribed steroids with follow up chest ultrasound yet to be scheduled. Note: I've used pine cleaners for years and never had such an intense reaction before. I've since read about possible lung inflammation from the RSV vaccine and wondered if the vaccine might have inflamed my lung tissues and greatly magnified my reaction. I was told by one medical provider that it might be chemically induced bronchitis. If you all receive any reports of chemically induced bronchitis or pneumonia from recently RSV vaccinated patients, please research a possible adverse reaction connection. Thank you!
Age: 75.0
Sex: F
Vaccine: UNK
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Covid Pfizer Comirnaty Hc9275, received at pharmacy
Age: 56.0
Sex: F
Vaccine: FLU4
Symptoms: Candida infection, Diarrhoea, Dizziness, Fatigue, Headache
Clinical narrative: The day after flu vaccine 10/8/23 I woke up with headache, nausea, diarrhea, continue with headache, fatigue, dizziness, two days later developed thrush.  Provider prescribed Nystatin oral suspension.  As of today 10/17/23, feel little better.    Two of my daughters also received the flu vaccine same day same one also developed thrush.
Age: 56.0
Sex: F
Vaccine: FLU4
Symptoms: Nausea
Clinical narrative: The day after flu vaccine 10/8/23 I woke up with headache, nausea, diarrhea, continue with headache, fatigue, dizziness, two days later developed thrush.  Provider prescribed Nystatin oral suspension.  As of today 10/17/23, feel little better.    Two of my daughters also received the flu vaccine same day same one also developed thrush.
Age: 18.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Oedema, Pain, Rash, Rash vesicular
Clinical narrative: Blistering rash on right arm, then approx. 1 week later, blistering, dermatomal rash on left anterior leg with extreme pain, erythema, edema
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS  STORED IN AN UNAPPROVED STORAGE UNIT
Age: 60.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Ageusia, Anosmia
Clinical narrative: Loss of Smell and Taste,  4 days now.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Hemiparesis, Laboratory test, Magnetic resonance imaging, Speech disorder
Clinical narrative: LEFT SIDED WEAKNESS BODY AND SPEECH,
Age: 71.0
Sex: F
Vaccine: RSV
Symptoms: Arthralgia, Back pain, Chills, Headache, Hypoaesthesia
Clinical narrative: Patient stated that the morning after the vaccine she woke up and she "felt like she had a stroke". She noted that she had pain/numbness on left side of body (pt noted neck/arm/should/back/leg) only on side she had vaccine given on. She said she had a headache and chills as well. She rested and took Aleve.  She estimated that symptoms lasted about 8-10 hours and said she was starting to feel better by the evening  and symptoms were totally resolved after 24 hours.
Age: 71.0
Sex: F
Vaccine: RSV
Symptoms: Injection site hypoaesthesia, Neck pain, Pain in extremity
Clinical narrative: Patient stated that the morning after the vaccine she woke up and she "felt like she had a stroke". She noted that she had pain/numbness on left side of body (pt noted neck/arm/should/back/leg) only on side she had vaccine given on. She said she had a headache and chills as well. She rested and took Aleve.  She estimated that symptoms lasted about 8-10 hours and said she was starting to feel better by the evening  and symptoms were totally resolved after 24 hours.
Age: 43.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site warmth
Clinical narrative: On the morning following vaccination, patient noted a painful reddened area at the site of the injection.  Upon assessment, this RN noted an area of redness approximately 3" in diameter, which is firm and hot to touch.  Patient had not yet taken anything for relief of these symptoms.  Patient would like to monitor symptoms from home and consult with Occupational Health if symptoms worsen, or do not resolve on their own.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS  STORED IN AN UNAPPROVED STORAGE UNIT
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS  STORED IN AN UNAPPROVED STORAGE UNIT
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: pt received the Pfizer vaccine 2023-2024 booster dose for the age 5-11 years (10mcg) in error, due to age pt should have received the Pfizer Covid vaccine 2023-2024 6month-4 years (3mcg) at visit
Age: 15.0
Sex: M
Vaccine: FLUR4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Pt received Flublok recommened for 18 years and older.  Pt is age 15 years old.   Mother states pt reacted fine to vacccine.  No adverse side effects.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Pt came back to pharmacy approximately 20 to 30 minutes after IMZ administration complaining of "really itchy hands". Gave 25mg of diphenhydramine. Pt states did not experience any other symptoms at the time.
Age: 66.0
Sex: M
Vaccine: FLU4
Symptoms: Cough, Drainage, Eye pain, Fatigue, Headache
Clinical narrative: I woke up in the early hours of 10/13/23 with a headache and pressure in my sinuses and a sore throat. Body aches. Headaches got worse and so did the sinus pressure. Ringing in the ears. Severe fatigue. Excessive and nasty drainage. A horrible cough. I went through 6 large paper towel rolls to clean up the amount of drainage I was producing. My right eye swelled shut. Minor eye pain when I look left or right. Doing a little better today.
Age: 66.0
Sex: M
Vaccine: FLU4
Symptoms: Oropharyngeal pain, Pain, Paranasal sinus discomfort, SARS-CoV-2 test negative, Swelling of eyelid
Clinical narrative: I woke up in the early hours of 10/13/23 with a headache and pressure in my sinuses and a sore throat. Body aches. Headaches got worse and so did the sinus pressure. Ringing in the ears. Severe fatigue. Excessive and nasty drainage. A horrible cough. I went through 6 large paper towel rolls to clean up the amount of drainage I was producing. My right eye swelled shut. Minor eye pain when I look left or right. Doing a little better today.
Age: 66.0
Sex: M
Vaccine: FLU4
Symptoms: Tinnitus
Clinical narrative: I woke up in the early hours of 10/13/23 with a headache and pressure in my sinuses and a sore throat. Body aches. Headaches got worse and so did the sinus pressure. Ringing in the ears. Severe fatigue. Excessive and nasty drainage. A horrible cough. I went through 6 large paper towel rolls to clean up the amount of drainage I was producing. My right eye swelled shut. Minor eye pain when I look left or right. Doing a little better today.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS  STORED IN AN UNAPPROVED STORAGE UNIT
Age: 60.0
Sex: F
Vaccine: COVID19-2, FLU4, RSV, VARZOS
Symptoms: Headache, Influenza like illness, Malaise, Oropharyngeal pain, Pain in extremity
Clinical narrative: Patient states she started having adverse effects just prior to midnight after receiving her 4 vaccinations earlier in the day.  She stated she is so sick, said she feels like she has flu and Covid both. Patient states both arms hurt, headache, sore throat, fever, constantly urinating, and could not sleep all night last night.   Patient was advised to call her Dr and she did not want to.
Age: 60.0
Sex: F
Vaccine: COVID19-2, FLU4, RSV, VARZOS
Symptoms: Pollakiuria, Pyrexia, Sleep disorder
Clinical narrative: Patient states she started having adverse effects just prior to midnight after receiving her 4 vaccinations earlier in the day.  She stated she is so sick, said she feels like she has flu and Covid both. Patient states both arms hurt, headache, sore throat, fever, constantly urinating, and could not sleep all night last night.   Patient was advised to call her Dr and she did not want to.
Age: 63.0
Sex: M
Vaccine: COVID19-2
Symptoms: Urticaria
Clinical narrative: Hives that looks like urticaria near both knees and both elbows. Took Benadryl and hives gone after 30 minutes.   8 house later hives developed on upper thigh and side of lower back.  Took another Benadryl and cleared up again after 30 minutes.  That is where I am now, unsure if cycle will repeat. Will see my primary car doctor if continues.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: pt had all over body hives that she took benadryl for, which resolved after 2 days
Age: 75.0
Sex: F
Vaccine: COVID19, RSV
Symptoms: Erythema, Skin warm
Clinical narrative: Redness that extended down arm. Warm to touch. Still present 3 days after the vaccine was given.
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 2nd dose was given after only 1 month (10/24/2022)